Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Plans Initiating Coverage Of Claritin, Prilosec OTC – PBMI Survey

This article was originally published in The Tan Sheet

Executive Summary

Schering-Plough's non-sedating antihistamine Claritin is being covered by 10% of employers, according to a survey by the Pharmacy Benefit Management Institute

You may also be interested in...



Arkansas Prilosec OTC Coverage Offers Savings Model For Plan Sponsors

An Arkansas state health plan that covers use ofPrilosec OTC provides a blueprint for plan sponsors looking to nonprescription drugs for cost savings

Arkansas Prilosec OTC Coverage Offers Savings Model For Plan Sponsors

An Arkansas state health plan that covers use ofPrilosec OTC provides a blueprint for plan sponsors looking to nonprescription drugs for cost savings

Caremark Hopes OTC Alternatives To Rx Drugs Will Lead To Savings In 2006

Pharmacy benefit manager Caremark will look to over-the-counter substitutes for branded prescription therapies to generate savings in 2006, according to CEO Mac Crawford

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097457

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel